Approaches to manage 'affordability' of high budget impact medicines in key EU countries Approaches to manage 'affordability' of high budget impact medicines in key EU countries (original ) (raw )Approaches to manage 'affordability' of high budget impact medicines in key EU countries
Nicolas Touchot
Journal of market access & health policy, 2018
View PDFchevron_right
Fair Pricing of Innovative Medicines: An EHA Position Paper
John Gribben
HemaSphere, 2020
View PDFchevron_right
Affordability of medicines in the European Union
Elzbieta Nowakowska
PloS one, 2017
View PDFchevron_right
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Guenka Petrova
Frontiers in Public Health
View PDFchevron_right
Defining and Measuring the Affordability of New Medicines: A Systematic Review
Paul Overton
PharmacoEconomics, 2017
View PDFchevron_right
Pharmaceutical Pricing in Europe: Weighing up the Options
Elias Mossialos
International Social Security Review, 2006
View PDFchevron_right
AFFORDABILITY OF MEDICINES AND DIAGNOSTICS
Tamas Bereczky
View PDFchevron_right
Valorising and Creating Access to Innovative Medicines in the European Union
Steven Simoens
Frontiers in Pharmacology, 2011
View PDFchevron_right
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future
Newman Madzikwa
Frontiers in Pharmacology, 2016
View PDFchevron_right
Cost-Containment Policies in Public Pharmaceutical Spending in the EU
Giuseppe Carone
SSRN Electronic Journal, 2000
View PDFchevron_right
From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries
Reinhard Busse
Health research policy and systems / BioMed Central, 2015
View PDFchevron_right
Fighting Excessive Pharmaceutical Prices: Evaluating the Options
ANDRE DEN EXTER
European Journal of Health Law, 2020
View PDFchevron_right
Value-based drug price schemes: a welfare analysis
Rosella Levaggi
Journal of Pharmaceutical Health Services Research, 2021
View PDFchevron_right
A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing
Ulf Persson
Applied Health Economics and Health Policy, 2012
View PDFchevron_right
Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
José A Sacristán
Value in Health, 2020
View PDFchevron_right
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market
Davor Mance
Croatian Medical Journal, 2016
View PDFchevron_right
Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies
Fatima Suleman
Journal of Pharmaceutical Policy and Practice, 2019
View PDFchevron_right
The consequences of greater net price transparency for innovative medicines in Europe: Searching for a consensus
Pius Gyger
2020
View PDFchevron_right
Application of the Price-Volume Approach in Cases of Innovative Drugs Where Value-Based Pricing is Inadequate: Description of Real Experiences in Italy
Andrea Messori
Clinical drug investigation, 2016
View PDFchevron_right
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways
Silvia Cammarata
Clinical pharmacology and therapeutics, 2016
View PDFchevron_right
Cost Containment Measures for Pharmaceuticals Expenditure in the EU Countries: A Comparative Analysis
Wim Groot
The Open Health Services and Policy Journal, 2009
View PDFchevron_right
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
Bengt Jonsson
The European Journal of Health Economics, 2011
View PDFchevron_right
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
Claudio Jommi
Journal of Pharmaceutical Policy and Practice, 2021
View PDFchevron_right
COVID-19 and the global public health: Tiered pricing of pharmaceutical drugs as a price-reducing policy tool
Muhammad Abbas
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector
View PDFchevron_right